News and Trends 28 Jul 2022
Kelun-Biotech announces joint license agreement with MSD for drug targeting solid tumors
…therapeutics as well as small molecule discovery and development. The company’s current pipeline includes 55 therapeutic programs for the treatment of cancers, autoimmune conditions, infectious diseases, and metabolic syndromes. development….